PharmaShots | Incisive News in 3 Shots

Subscribe Now

Vifor

Vifor & Cara’s Kapruvia (difelikefalin) Receive EC’s Approval for the Treatment of Pruritus in Hemodialysis Patients

Vifor & Cara’s Kapruvia (difelikefalin) Receive EC’s Approval for the Treatment of Pruritus in Hemodialysis Patients

April 28, 2022

Vifor and Angion Report Results of ANG-3777 in P-II (GUARD) Trial for Cardiac Surgery Associated Acute Kidney Injury

Vifor and Angion Report Results of ANG-3777 in P-II (GUARD) Trial for Cardiac Surgery Associated Acute Kidney Injury

December 10, 2021

PharmaShots Weekly Snapshots (October 25 - 29, 2021)

PharmaShots Weekly Snapshots (October 25 - 29, 2021)

October 29, 2021

Insights+: The US FDA New Drug Approvals in August 2021

Insights+: The US FDA New Drug Approvals in August 2021

September 16, 2021

PharmaShots Weekly Snapshots (August 23, 27, 2021)

PharmaShots Weekly Snapshots (August 23, 27, 2021)

August 27, 2021

Cara and Vifor's Korsuva (difelikefalin) Receive the US FDA's Approval for the Treatment of Moderate-to-Severe Pruritus Due to CKD in Patients with Hemodialysis

Cara and Vifor's Korsuva (difelikefalin) Receive the US FDA's Approval for the Treatment of Moderate-to-Severe Pruritus Due to CKD...

August 25, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us